1. Home
  2. PULM vs RAY Comparison

PULM vs RAY Comparison

Compare PULM & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • RAY
  • Stock Information
  • Founded
  • PULM 2003
  • RAY 1993
  • Country
  • PULM United States
  • RAY Hong Kong
  • Employees
  • PULM N/A
  • RAY N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • RAY Consumer Electronics/Appliances
  • Sector
  • PULM Health Care
  • RAY Consumer Discretionary
  • Exchange
  • PULM Nasdaq
  • RAY Nasdaq
  • Market Cap
  • PULM 18.3M
  • RAY 19.5M
  • IPO Year
  • PULM N/A
  • RAY 2024
  • Fundamental
  • Price
  • PULM $4.84
  • RAY $1.60
  • Analyst Decision
  • PULM
  • RAY
  • Analyst Count
  • PULM 0
  • RAY 0
  • Target Price
  • PULM N/A
  • RAY N/A
  • AVG Volume (30 Days)
  • PULM 4.3K
  • RAY 544.6K
  • Earning Date
  • PULM 10-16-2025
  • RAY 01-01-0001
  • Dividend Yield
  • PULM N/A
  • RAY N/A
  • EPS Growth
  • PULM N/A
  • RAY N/A
  • EPS
  • PULM N/A
  • RAY 0.98
  • Revenue
  • PULM $3,000.00
  • RAY $10,120,519.00
  • Revenue This Year
  • PULM N/A
  • RAY N/A
  • Revenue Next Year
  • PULM $134.88
  • RAY N/A
  • P/E Ratio
  • PULM N/A
  • RAY $1.70
  • Revenue Growth
  • PULM N/A
  • RAY 17.57
  • 52 Week Low
  • PULM $4.26
  • RAY $1.40
  • 52 Week High
  • PULM $10.40
  • RAY $58.88
  • Technical
  • Relative Strength Index (RSI)
  • PULM 47.70
  • RAY 56.94
  • Support Level
  • PULM $4.26
  • RAY $1.40
  • Resistance Level
  • PULM $4.85
  • RAY $2.70
  • Average True Range (ATR)
  • PULM 0.24
  • RAY 0.27
  • MACD
  • PULM -0.02
  • RAY 0.00
  • Stochastic Oscillator
  • PULM 61.11
  • RAY 49.49

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About RAY Raytech Holding Limited Ordinary Shares

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.

Share on Social Networks: